We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

University of Oxford Partners With AstraZeneca To Accelerate Globalization of COVID-19 Vaccine in Clinical Trials

News   Apr 30, 2020 | By Molly Campbell, Science Writer, Technology Networks

 
University of Oxford Partners With AstraZeneca To Accelerate Globalization of COVID-19 Vaccine in Clinical Trials
 
 
Advertisement
 

RELATED ARTICLES

Marine Molecules With Therapeutic Potential Against Alzheimer's Disease

News

A study has discovered two potential candidates to treat Alzheimer’s disease. The two marine molecules, meridianine and lignarenone B, can alter the activity of GSK3B activity, a protein linked to several neurodegenerative diseases.

READ MORE

Immune Disease Model Points to Treatment for COVID-19 Cytokine Storms

News

Researchers have developed a transgenic mouse to model the deadly childhood immune disease hemophagocytic lymphohistiocytosis, they hope that this model could aid development of a treatment for COVID-related cytokine storms

READ MORE

Attacking Cancer Cells With Viruses

News

Scientists have made an adenovirus that specifically replicates inside and kills cancer cells by employing special RNA-stabilizing elements.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE